Abeona Therapeutics, Inc. (ABEO)
4.41
-0.02
(-0.45%)
USD |
NASDAQ |
Oct 19, 16:00
4.41
0.00 (0.00%)
After-Hours: 20:00
Abeona Therapeutics Price : 4.41 for Oct. 19, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 4.66 | 4.66 | 4.39 | 4.43 | 819512.0 |
| Oct 15, 2026 | 4.39 | 4.785 | 4.35 | 4.65 | 1.377M |
| Oct 14, 2026 | 4.48 | 4.51 | 4.28 | 4.36 | 1.774M |
| Oct 13, 2026 | 4.88 | 4.88 | 4.505 | 4.52 | 1.980M |
| Oct 12, 2026 | 4.93 | 4.945 | 4.855 | 4.90 | 758415.0 |
| Oct 09, 2026 | 4.94 | 5.04 | 4.885 | 4.94 | 1.285M |
| Oct 08, 2026 | 5.04 | 5.05 | 4.94 | 4.96 | 1.625M |
| Oct 07, 2026 | 4.95 | 5.10 | 4.93 | 5.08 | 738343.0 |
| Oct 06, 2026 | 5.16 | 5.16 | 4.89 | 5.01 | 1.428M |
| Oct 05, 2026 | 5.07 | 5.16 | 4.985 | 5.11 | 1.404M |
| Oct 02, 2026 | 5.09 | 5.105 | 4.985 | 5.03 | 1.214M |
| Oct 01, 2026 | 5.22 | 5.25 | 4.985 | 5.01 | 1.476M |
| Sep 30, 2026 | 5.16 | 5.33 | 5.10 | 5.25 | 1.131M |
| Sep 29, 2026 | 5.30 | 5.30 | 5.11 | 5.16 | 1.254M |
| Sep 28, 2026 | 5.35 | 5.40 | 5.19 | 5.29 | 872884.0 |
| Sep 25, 2026 | 5.45 | 5.475 | 5.335 | 5.40 | 720708.0 |
| Sep 24, 2026 | 5.59 | 5.59 | 5.38 | 5.43 | 852416.0 |
| Sep 23, 2026 | 5.82 | 5.90 | 5.52 | 5.53 | 1.190M |
| Sep 22, 2026 | 5.71 | 5.865 | 5.69 | 5.82 | 1.020M |
| Sep 21, 2026 | 5.66 | 5.68 | 5.59 | 5.67 | 1.013M |
| Sep 18, 2026 | 5.82 | 5.84 | 5.525 | 5.57 | 2.772M |
| Sep 17, 2026 | 5.69 | 5.74 | 5.37 | 5.59 | 3.463M |
| Sep 16, 2026 | 5.51 | 5.549 | 5.215 | 5.37 | 1.903M |
| Sep 15, 2026 | 5.42 | 5.56 | 5.32 | 5.47 | 1.935M |
| Sep 14, 2026 | 5.41 | 5.525 | 5.37 | 5.43 | 1.416M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ultragenyx Pharmaceutical, Inc. | 15.07 |
| ACADIA Pharmaceuticals, Inc. | 19.81 |
| Alnylam Pharmaceuticals, Inc. | 233.37 |
| Anika Therapeutics, Inc. | 20.24 |
| Savara, Inc. | 4.635 |
Price Related Metrics
| PS Ratio | 9.632 |
| Price to Book Value | 1.971 |
| Earnings Yield | -25.45% |
| Market Cap | 252.37M |